{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:45:27Z","timestamp":1753890327799,"version":"3.41.2"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>There are numerous treatment options available for patients with confirmed hepatocellular carcinoma (HCC). Guidelines such as Barcelona Clinic Liver Cancer (BCLC) support treatment decisions by way of a flow diagram that is organized around groups of patients. Though such guidelines continue to make a major contribution to standardization of treatment, in clinical reality, cases are often more nuanced than is captured in any flow diagram, even one as comprehensive as BCLC. A fundamental challenge for a clinician is to combine such a population-wide guideline with specific information about the individual patient. Bayesian networks (BNs) offer a way to \u201cbridge this gap\u201d and combine standardized care and precision medicine. They do this by enabling answers to detailed \u201cwhat-if\u201d questions from the clinician.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We use real-world data of HCC patients who received treatments between 2019 and 2020 to construct a BN to assess the potential treatment effect for cases that were <jats:bold><jats:italic>not<\/jats:italic><\/jats:bold> treated in compliance with BCLC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We report detailed scenarios for ten randomly selected cases and summarise the difference in survival time for each scenario. For each case, the counterfactual treatment scenarios are made based on whether or not the case is in compliance with BCLC guidelines, the type of treatment received and the waiting time to receive treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>We consider two cases with similar clinical characteristics (but received different treatments) and discuss whether or not they are treated in compliance to the guidelines resulting in better outcomes than the actual clinical decision. We include a detailed discussion about the assumptions made in constructing the BN and we highlight why such a BN can serve as an AI-based clinical decision support system particularly when there is need for further patient stratification.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbinf.2025.1574797","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:25:03Z","timestamp":1748496303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the gap between hepatocellular carcinoma management guidelines and personalised medicine: a Bayesian network study"],"prefix":"10.3389","volume":"5","author":[{"given":"Yi-Chun","family":"Wang","sequence":"first","affiliation":[]},{"given":"Daniel","family":"Bulte","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Brady","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10353-018-0537-x","article-title":"Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma","volume":"50","author":"Braunwarth","year":"2018","journal-title":"Eur. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/s0269888910000251","article-title":"Learning Bayesian networks: approaches and issues","volume":"26","author":"Daly","year":"2011","journal-title":"Knowl. Eng. Rev."},{"key":"B4","first-page":"609","article-title":"pyAgrum: a toolbox to build models and algorithms for probabilistic graphical models in Python","volume":"138","author":"Ducamp","year":"2020","journal-title":"Proc. Tenth Int. Conf. Probabilistic Graph. Models, Proc. Mach. Learn. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41591-024-02902-1","article-title":"Causal machine learning for predicting treatment outcomes","volume":"30","author":"Feuerriegel","year":"2024","journal-title":"Nat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e000794","DOI":"10.1136\/bmjgast-2021-000794","article-title":"COVID-19 and liver cancer: lost patients and larger tumours","volume":"9","author":"Geh","year":"2022","journal-title":"BMJ Open Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1148\/rg.220022","article-title":"Local-regional treatment of hepatocellular carcinoma: a primer for radiologists","volume":"42","author":"Horvat","year":"2022","journal-title":"RadioGraphics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance \u2014 utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B11","first-page":"456","volume-title":"Causal inference and discovery in Python: unlock the secrets of modern causal machine learning with DoWhy, EconML, PyTorch and more. Birmingham","author":"Molak","year":"2023"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1371\/journal.pcbi.0030129","article-title":"A primer on learning in bayesian networks for computational biology","volume":"3","author":"Needham","year":"2007","journal-title":"PLOS Comput. Biol."},{"volume-title":"The book of why: the new science of cause and effect","year":"2018","author":"Pearl","key":"B13"},{"key":"B14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"article-title":"On noise abduction for answering counterfactual queries: a practical outlook","year":"2022","author":"Saha","key":"B15"},{"key":"B16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0034-1394142","article-title":"Transarterial chemoembolization and radioembolization","volume":"34","author":"Sangro","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"B17","unstructured":"Bnlearn - imputing missing data from a Bayesian network\n          \n          \n            \n              Scutari\n              M.\n            \n          \n          \n          2024"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12874-020-01191-9","article-title":"Virtual controls as an alternative to randomized controlled trials for assessing efficacy of interventions","volume":"21","author":"Strayhorn","year":"2021","journal-title":"BMC Med. Res. Methodol."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1574797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:25:07Z","timestamp":1748496307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1574797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":17,"alternative-id":["10.3389\/fbinf.2025.1574797"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1574797","relation":{},"ISSN":["2673-7647"],"issn-type":[{"type":"electronic","value":"2673-7647"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1574797"}}